Physician

Sridevi Rajeeve, MD

According to 2025 Medicare claims, Sridevi Rajeeve, MD (NPI: 1154843944) practices hematopoietic cell transplantation and cellular therapy in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Monmouth, NJ. This provider's primary affiliated billing organization is MSK MONMOUTH (NPI: 1922459163; TIN: 300937486) and primary practice location at 07748-3052.

Rajeeve's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 104 traditional Medicare patients, billed 427 HCPCS/CPT codes, and received $44,171 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 462 prescription claims across 92 beneficiaries totaling $2,147,614 in drug costs, led by Lenalidomide (Lenalidomide). Open Payments data shows 14 records totaling $5,323. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $2,477 to $2,147,614. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$22K$44K2023 Medicare payment: $14,317 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $44,171 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
202328153$14,317
2024104427$44,171

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.1M$2.1M2017 Drug cost: $2,477 (USD; Tot_Drug_Cst)2018 Drug cost: $2,305 (USD; Tot_Drug_Cst)2019 Drug cost: $11,397 (USD; Tot_Drug_Cst)2020 Drug cost: $21,998 (USD; Tot_Drug_Cst)2023 Drug cost: $178,099 (USD; Tot_Drug_Cst)2024 Drug cost: $2,147,614 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20171127$2,477
20181770$2,305
201929122$11,397
2020N/R61$21,998
2021N/RN/RN/R
2022N/RN/RN/R
20231550$178,099
202492462$2,147,614

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more3535$151
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more47171$127
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes2659$103
99239Hospital discharge day management, more than 30 minutes1515$99
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more3145$95

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LenalidomideLenalidomide742,072$1,035,057
RevlimidLenalidomide491,372$920,512
XareltoRivaroxaban15870$15,583
EliquisApixaban14630$12,483
AcyclovirAcyclovir964,168$1,411

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.14$5,323Janssen Global Services, LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Sridevi Rajeeve, MD?

Tedicare shows public-source Medicare data for Sridevi Rajeeve, MD (NPI 1154843944), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sridevi Rajeeve, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sridevi Rajeeve, MD?

Sridevi Rajeeve, MD is linked to MSK MONMOUTH (billing NPI 1922459163) in the available physician profile data.

Does Sridevi Rajeeve, MD have Open Payments data?

Sridevi Rajeeve, MD has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.